Valerio Therapeutics SA
SWB:C4X

Watchlist Manager
Valerio Therapeutics SA Logo
Valerio Therapeutics SA
SWB:C4X
Watchlist
Price: 0.054 EUR Market Closed
Market Cap: 27.8m EUR

Wall Street
Price Targets

C4X Price Targets Summary
Valerio Therapeutics SA

There are no price targets for C4X.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Valerio Therapeutics SA Competitors:
Price Targets
300142
Walvax Biotechnology Co Ltd
36% Downside
NVAX
Novavax Inc
89% Upside
MDGL
Madrigal Pharmaceuticals Inc
1% Upside
XGN
Exagen Inc
137% Upside
206650
EuBiologics Co Ltd
64% Upside
SERA
Sera Prognostics Inc
42% Upside
CSL
CSL Ltd
39% Upside
RCKT
Rocket Pharmaceuticals Inc
128% Upside

Revenue
Forecast

Revenue Estimate
Valerio Therapeutics SA

For the last 13 years the compound annual growth rate for Valerio Therapeutics SA's revenue is -4%. The projected CAGR for the next 2 years is 247%.

-4%
Past Growth
247%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Valerio Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Valerio Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is C4X's stock price target?
Not Available

C4X doesn't have any price targets made by Wall Street professionals.

What is Valerio Therapeutics SA's Revenue forecast?
Projected CAGR
247%

For the last 13 years the compound annual growth rate for Valerio Therapeutics SA's revenue is -4%. The projected CAGR for the next 2 years is 247%.

Back to Top